ClinConnect ClinConnect Logo
Search / Trial NCT03776916

Application of Simethicone in Esophagogastroscopy

Launched by AFFILIATED HOSPITAL TO ACADEMY OF MILITARY MEDICAL SCIENCES · Dec 13, 2018

Trial Information

Current as of April 28, 2025

Completed

Keywords

ClinConnect Summary

Esophagogastroscopy can enable the direct examination of the esophageal and gastric mucosal lesions, which has been widely applied in clinical practice. However, during the examination, too much water, foam or residues in the stomach will not only increase the procedure time and the misdiagnosis rate, but also decrease the patients' tolerance, for more efforts should be made to deal with the excessive water, foam or residues in order to obtain a clear view of the mucosa. Simethicone is also called poly-dimethylsiloxane, which can be used to remove the foam and water. Although simethicone ha...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Above 18 years old patients
  • Who agree to participate in the study
  • Patients with the indications for gastroduodenoscopy
  • Exclusion Criteria:
  • Patients, who were receiving nonsteroidal anti-inflammatory drugs, pump inhibitors (PPI) or antibiotics in the last 3 weeks.
  • Severe uncontrolled coagulopathy
  • Prior history of gastric surgery.
  • Pregnancy and lactation

About Affiliated Hospital To Academy Of Military Medical Sciences

The Affiliated Hospital to the Academy of Military Medical Sciences is a leading clinical trial sponsor dedicated to advancing medical research and improving patient care. With a strong emphasis on innovation and excellence, the institution combines military medical expertise with cutting-edge research methodologies. It collaborates closely with academic and healthcare professionals to conduct rigorous clinical trials across various therapeutic areas, ensuring compliance with ethical standards and regulatory requirements. The hospital is committed to fostering a culture of scientific inquiry and delivering impactful healthcare solutions that benefit both military and civilian populations.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yan Liu

Principal Investigator

PLA General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials